I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-23-063) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Application receipt date: May 29, 2023
Earliest start date: April 2024
We strongly encourage all Phase 1 COBRE awardees and institutional officials to attend our upcoming webinar:
Thursday, January 12, 2:30-4:00 p.m. ET
Zoom Meeting link (Link no longer available)
During the webinar, we’ll present an overview of the COBRE Phase 2 program’s objectives; go over changes from the prior FOA, emphasizing eligibility and reporting requirements; and highlight other key aspects of PAR-23-063. We’ll also answer your questions.
Participants are encouraged to submit questions prior to the webinar by contacting me no later than January 10. Those requiring sign language interpretation and/or other reasonable accommodations should submit a request using our contact form at least 5 days prior to the webinar.
The webinar and presentation slides will be posted on the COBRE webpage following the event.